Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01623154

POCone-UBiT-IR300 Pediatric Comparison Study

Bacterial Infection Due to Helicobacter Pylori (H. Pylori) Clinical Trial

Official title:
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the UBiT®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms

Clinical Trial Summary

The purpose of this study is to compare between the POCone® to the UBiT®-IR300 in measuring 13CO2/12CO2 ratio in breath samples when used together with the BreathTek® UBT (urea breath test) Kit and the pUHR-CA web-based software program in identifying H. pylori infection in pediatric subjects.

Clinical Trial Description

The same patients will be tested on both the POCone® and UBiT®-IR300. If the patients test positive for H. pylori, they will be given eradication medication and brought back in for a re-test. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01623154
Study type Interventional
Source Otsuka America Pharmaceutical
Contact
Status Completed
Phase Phase 4
Start date July 2012
Completion date April 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02553083 - High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection Phase 4
Completed NCT01897909 - The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana
Completed NCT02160860 - Epidemiology of Helicobacter Pylori Infection Among Shanghai Children N/A
Completed NCT03367897 - Bleeding Ulcer and Erosions Study "BLUE Study"
Completed NCT01506986 - Helicobacter Eradication Aspirin Trial Phase 4
Recruiting NCT01572597 - Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy Phase 4
Recruiting NCT02164409 - Changes Associated With H. Pylori and Gastric Carcinogenesis
Completed NCT01591486 - Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding N/A
Completed NCT03124199 - Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection Phase 3
Recruiting NCT02674802 - Reinfection After Eradication of Helicobacter Pylori Infection N/A
Completed NCT02092506 - RCT: Triple vs Sequential vs Concomitant Therapy H Pylori Phase 4
Completed NCT01902589 - Resistance of Helicobacter Pylori to Antibiotics in Children N/A